Skip to main content
GRCE logo

GRCE · Grace Therapeutics, Inc.

$2.43 +0.00 (+0.00%) At close · Jul 21
Market Cap
$38.81M
Shares
16.27M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-06-23 1,054 $2.26 $2,382
2026-06-17 15,836 $2.22 $35,156
2026-06-16 16,995 $2.21 $37,559
2026-06-15 8,015 $2.20 $17,633
2026-06-12 84 $2.30 $193
2026-06-11 84 $2.31 $194
2026-06-09 1,426 $2.30 $3,280
2026-05-29 59 $2.43 $143
2026-05-28 284 $2.33 $662
2026-05-27 1,230 $2.36 $2,903
2026-05-26 2,666 $2.20 $5,865
2026-05-22 5 $2.24 $11
2026-05-21 325 $2.18 $709
2026-05-20 2,067 $2.15 $4,444
2026-05-19 74,080 $2.17 $160,754
2026-05-18 174,374 $2.16 $376,648
2026-05-15 100 $2.19 $219
2026-05-14 100 $2.25 $225
2026-05-12 6,187 $2.35 $14,539
2026-05-08 14,867 $2.25 $33,451
2026-05-07 12,165 $2.37 $28,831
2026-05-06 1,120 $2.33 $2,610
2026-05-05 2,173 $2.36 $5,128
2026-05-04 442 $2.34 $1,034
2026-05-01 6,195 $2.24 $13,877
2026-04-28 18,584 $2.16 $40,141
2026-04-27 88,109 $2.30 $202,651
Showing 1–27 of 27 settlements
Key facts CIK 1444192 CUSIP 00439U104 13F (30d) 2 filings 2 filers Visit website Investor relations